Motley Fool Australia

Kazia Therapeutics Ltd (ASX: KZA) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $176.28 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 126.58 million
Earnings per share -0.140
Dividend per share N/A
Year To Date Return 18.97%
Earnings Yield N/A
Franking N/A

Kazia Therapeutics Ltd (ASX: KZA) Latest News

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies

Kazia (ASX:KZA) share price slides despite positive update

More »

increase in asx medical software share price represented by doctor making excited hands up gesture

Why the Kazia Therapeutics (ASX:KZA) share price is rocketing 11%

More »

biotech shares

Why Kazia Therapeutics share price has skyrocketed today

More »

Biotechnology graphics

Kazia Therapeutics share price soars 46% on new drug grant

More »

down

Why Novogen Limited has been slammed today

More »

fall down

5 stocks sinking on the ASX today

More »

Why these 4 ASX stocks are rampaging higher today

More »

fall down

4 stocks sliding on the ASX today

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Kazia Therapeutics Ltd (ASX: KZA)

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovariancancer; and Others.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
07 May 2021 $1.36 $-0.02 -1.45% 123,015 $1.38 $1.38 $1.35
06 May 2021 $1.38 $0.00 0.00% 58,002 $1.41 $1.41 $1.37
05 May 2021 $1.38 $-0.01 -0.72% 130,198 $1.39 $1.41 $1.38
04 May 2021 $1.39 $-0.01 -0.72% 88,996 $1.43 $1.43 $1.38
03 May 2021 $1.40 $0.00 0.00% 101,997 $1.40 $1.40 $1.37
30 Apr 2021 $1.40 $0.01 0.72% 52,532 $1.37 $1.40 $1.37
29 Apr 2021 $1.39 $0.00 0.00% 27,405 $1.37 $1.39 $1.37
28 Apr 2021 $1.39 $-0.01 -0.72% 19,631 $1.39 $1.39 $1.36
27 Apr 2021 $1.40 $0.01 0.72% 44,676 $1.39 $1.40 $1.37
26 Apr 2021 $1.39 $-0.01 -0.71% 70,156 $1.38 $1.40 $1.36
23 Apr 2021 $1.40 $0.05 3.70% 113,597 $1.36 $1.40 $1.36
22 Apr 2021 $1.35 $-0.12 -8.19% 415,315 $1.43 $1.43 $1.33
21 Apr 2021 $1.47 $-0.01 -0.68% 288,775 $1.42 $1.47 $1.40
20 Apr 2021 $1.48 $-0.05 -3.27% 359,344 $1.54 $1.55 $1.45
15 Apr 2021 $1.53 $-0.08 -4.97% 453,026 $1.53 $1.55 $1.48
14 Apr 2021 $1.61 $-0.10 -5.85% 300,378 $1.64 $1.66 $1.61
13 Apr 2021 $1.71 $-0.08 -4.48% 258,003 $1.66 $1.71 $1.63
12 Apr 2021 $1.79 $-0.04 -2.20% 269,644 $1.85 $1.85 $1.75
09 Apr 2021 $1.82 $-0.06 -3.19% 472,956 $1.85 $1.86 $1.78
08 Apr 2021 $1.88 $0.20 11.90% 712,050 $1.78 $1.88 $1.78
07 Apr 2021 $1.68 $0.08 4.98% 516,822 $1.66 $1.68 $1.62
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
03 May 2021 Steven Coffey Buy 7 $10,150
03 May 2021 James Garner Buy 20 $27,880
30 Apr 2021 Iain Ross Buy 25 $34,925
17 Dec 2020 Steven Coffey Buy 8 $10,540
17 Dec 2020 Steven Coffey Buy 8 $9,818
16 Dec 2020 Iain Ross Buy 30 $37,200
11 Dec 2020 James Garner Buy 37 $52,950
09 Nov 2020 James Garner Issued 800 $716,000
09 Nov 2020 Bryce Carmine Issued 400 $358,000
09 Nov 2020 Iain Ross Issued 400 $358,000
09 Nov 2020 Steven Coffey Issued 400 $358,000
12 Oct 2020 Iain Ross Issued 125 $100,000
12 Oct 2020 Steven Coffey Issued 62 $50,000
12 Oct 2020 Bryce Carmine Issued 62 $50,000
12 Oct 2020 James Garner Issued 62 $50,000
31 Aug 2020 Steven Coffey Expiry 5 $6,433
31 Aug 2020 Steven Coffey Buy 13 $14,432
28 Aug 2020 Bryce Carmine Buy 23 $303,250
27 Aug 2020 James Garner Buy 25 $25,450
27 Aug 2020 Iain Ross Buy 20 $20,120
25 May 2020 Iain Ross Buy 125 $51,325
11 May 2020 Bryce Carmine Issued 75 $30,000
11 May 2020 Steven Coffey Issued 75 $30,000
11 May 2020 Iain Ross Issued 75 $30,000
11 May 2020 James Garner Issued 75 $30,000
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Steven Roy Stent Coffey Non-Executive Director Nov 2012
Mr Iain Ross Non-Executive Director,Non-Executive Chairman Jul 2015
Mr Bryce Carmine Non-Executive Director Jun 2015
Dr James Garner Chief Executive Officer,Managing Director Feb 2016
Ms Catherine (Kate) Jane Hill Company Secretary Sep 2016
Catherine (Kate) Jane Hill Company Secretary
Gabrielle Heaton Director - Finance and Administration
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 39,899,895 42.18%
Willoughby Capital Pty Ltd 12,355,000 13.06%
Mna Family Holdings Pty Ltd 2,145,000 2.27%
Hishenk Pty Ltd 1,930,000 2.04%
BNP Paribas Noms Pty Ltd 1,687,141 1.78%
Jamplat Pty Ltd 970,000 1.03%
Citicorp Nominees Pty Umited 955,390 1.01%
Mr Iain Ross 800,001 0.85%
Comsec Nominees Pty Limited 589,104 0.62%
D& G Brown Investments Pty Limited 572,356 0.61%
Invia Custodian Pty Umited 544,354 0.58%
National Nominees Limited 505,194 0.53%
Mr Tony Mark Eldridge & Mrs Anita Maree Eldridge 505,000 0.53%
Bond Street Custodians Umited 500,000 0.53%
C & L Jackson Investments Pty Ltd 458,840 0.49%
El Coronado Holdings 453,164 0.48%
Mrs Janet Louise Bowtell & Mr Gary Owen Bowtell 360,000 0.38%
Mr Ross Richard Eddison 345,725 0.37%
CS Fourth Nominees Pty Limited 342,135 0.36%
Mrs Alison Louise Suters & Mr Mark Gerard Suters 340,076 0.36%
Show more